We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9917:TWSETaiwan Secom Co., Ltd. Analysis

Data as of 2026-06-13 - not real-time

NT$122.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Taiwan Secom is trading at TWD 122, just below its 52‑week high of 123.5 and above the computed resistance level of 122, indicating limited upside. The stock’s technical profile is mixed: the MACD line sits well above its signal line (bullish) and the 20‑day SMA (115.1) is comfortably under the current price, but the RSI of 77 signals that the share is in overbought territory and a short‑term pull‑back could arise. Volume has been increasing, supporting the recent rally, while the beta of just 0.04 underscores an exceptionally low sensitivity to market moves.
Fundamentally, the company appears value‑oriented. A trailing P/E of 18 is far below the industry average of ~30, yet the DCF‑derived fair value of TWD 77.6 suggests the market price is substantially stretched. The firm generates solid cash, with TWD 6.6 bn in cash and free cash flow of TWD 2.6 bn, and it returns a high dividend yield of 4.67% supported by a payout ratio of roughly 77%. However, the debt‑to‑equity ratio of 58.5% and a max drawdown of 15% add modest financial risk. Overall, the stock offers an attractive income stream but appears overvalued at current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but overbought RSI
  • Price at resistance level
  • Increasing volume supporting recent rally

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash generation and high dividend yield
  • Valuation stretch relative to DCF fair value
  • Low beta and stable sector demand

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend payout with solid cash flow
  • Low market sensitivity and defensive industry positioning
  • Potential price correction offering upside to fair value

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin15.83%
P/E Ratio18.0
ROE21.05%
ROA6.26%
Debt/Equity58.51
P/B Ratio6.0
Op. Cash FlowNT$4.0B
Free Cash FlowNT$2.6B
Industry P/E30.6

Technical Analysis

TrendBullish
RSI77.6
SupportNT$111.00
ResistanceNT$122.00
MA 20NT$115.08
MA 50NT$114.61
MA 200NT$110.55
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueNT$77.59
Target PriceNT$120.00
Upside/Downside-1.64%
GradeOvervalued
TypeValue
Dividend Yield4.67%

Risk Assessment

Beta0.04
Volatility12.89%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.